Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SHAZ yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Expand AI Factory platform capabilities | New partnerships could enhance their AI platform capabilities. | Intact | fails to launch new AI capabilities within the next 4 quarters | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 16, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth story, not an established compounder, because the business is loss-making and recent financial performance is weak. The multi-year view is in a watch state: infrastructure plans are advancing, but confidence in execution remains low.
The evidence snapshot gives no valuation measure or direct account of market expectations, so whether SHAZ is cheap or expensive versus peers cannot be assessed. Its recent performance has lagged its industry cohort, and the thesis depends on investors seeing progress in AI infrastructure despite continuing losses and funding needs.
Near term, revenue growth from the first to the second quarter of 2026 and a planned GPU deployment point to scaling activity, while the VAST Data partnership broadens platform capabilities. However, recent earnings misses, weak performance, and the recent accountant changes create execution and reporting concerns; the evidence does not establish that growth is profitable.
Over the multi-year period, the thesis hinges on deploying more than 68,000 GPUs by mid-2027, turning platform expansion and partnerships into stronger business results, and maintaining access to capital. Near term, lower interest rates and stabilization in major technology companies could support the sector backdrop, while GDP growth below 2% could weigh on growth-sensitive technology businesses.
For the next 1 to 3 years, SHAZ remains a high-risk, low-confidence AI infrastructure story with signs of operational progress but no evidence yet that scaling will resolve weak financial performance. The thesis depends on execution, funding access, and sector conditions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| SharonAI is securing significant debt to fund GPU deployments. |
| Intact |
| fails to secure additional debt facilities over the next 4 quarters |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue growth of $104 million | A primary condition in SharonAI Holdings, Inc.'s published investment case. The stated target is >=104 million. | Intact | revenue falls below $104 million in FY26 | Revenue: $1.931M FY2026-Q2; GAAP. Published target: >=104 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 20261,931,381 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-2.00 → $-3.50 · observed estimates
$1.52B → $1.36B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-27 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-08-28 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-08-29 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-08-30 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-08-31 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-01 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-02 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-03 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-04 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-05 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-06 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-07 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-08 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-09 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-10 | $-2.00 | $1,520,937,000 | 1 / 3 |
| 2026-09-11 | $-2.00 | $1,520,940,000 | 1 / 3 |
| 2026-09-12 | $-2.00 | $1,520,940,000 | 1 / 3 |
| 2026-09-13 | $-2.00 | $1,520,940,000 | 1 / 3 |
| 2026-09-14 | $-2.00 | $1,520,940,000 | 1 / 3 |
| 2026-09-15 | $-2.00 | $1,520,940,000 | 1 / 3 |
| 2026-09-16 | $-2.00 | $1,520,940,000 | 1 / 3 |
| 2026-09-17 | $-2.00 | $1,520,940,000 | 1 / 3 |
| 2026-09-18 | $-2.00 | $1,520,940,000 | 1 / 3 |
| 2026-09-19 | $-3.04 | $1,523,283,333 | 1 / 3 |
| 2026-09-20 | $-3.04 | $1,523,283,333 | 2 / 3 |
| 2026-09-21 | $-3.04 | $1,523,283,333 | 2 / 3 |
| 2026-09-22 | $-3.31 | $1,534,616,667 | 2 / 3 |
| 2026-09-23 | $-3.31 | $1,534,616,667 | 2 / 3 |
| 2026-09-24 | $-3.31 | $1,534,616,667 | 2 / 3 |
| 2026-09-25 | $-3.31 | $1,534,616,667 | 2 / 3 |
| 2026-09-26 | $-2.75 | $1,534,616,667 | 2 / 3 |
| 2026-09-27 | $-2.08 | $1,362,100,000 | 2 / 3 |
| 2026-09-28 | $-2.08 | $1,362,100,000 | 2 / 3 |
| 2026-09-29 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-09-30 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-01 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-02 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-03 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-04 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-05 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-06 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-07 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-08 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-09 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-10 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-11 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-12 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-13 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-14 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-15 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-16 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-17 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-18 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-19 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-20 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-21 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-22 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-23 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-24 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-25 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-26 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-27 | $-2.75 | $1,362,100,000 | 2 / 3 |
| 2026-10-28 | $-2.75 | $1,362,100,000 | 2 / 4 |
| 2026-10-29 | $-2.75 | $1,362,100,000 | 2 / 4 |
| 2026-10-30 | $-2.75 | $1,362,100,000 | 2 / 4 |
| 2026-10-31 | $-3.50 | $1,362,097,857 | 2 / 4 |
| 2026-11-01 | $-3.50 | $1,362,097,857 | 2 / 4 |
| 2026-11-02 | $-3.50 | $1,362,097,857 | 2 / 4 |
| 2026-11-03 | $-3.50 | $1,362,097,857 | 2 / 4 |
| 2026-11-04 | $-3.50 | $1,362,097,857 | 2 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.